Bilenker Joshua H.
President & CEO at Loxo Oncology, Inc.
- Sold, on record
- $43.2M
- Dollars the filings state
- Form 4 sales
- 17
- Latest Dec 11, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Loxo Oncology, Inc.President & CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Loxo Oncology, Inc.Plan not statedMay 15, 2018 2018
Sold 15,000 shares at $136.51 ($2M)
Bilenker Joshua H., President & CEO
Sold 7.6% of holdings ($27M position)182,707 shares left1x usual sizeFiling
- 2 Form 4 sale Loxo Oncology, Inc.UnusualJun 20, 2018 +36 days
Sold 57,000 shares at $178.62 ($10.2M)
Bilenker Joshua H., President & CEO
Sold 26.8% of holdings ($38M position)155,707 shares left3.8x usual sizeFiling
- 3 Form 4 sale Loxo Oncology, Inc.Plan not statedJul 10, 2018 +20 days
Sold 15,000 shares at $183.48 ($2.8M)
Bilenker Joshua H., President & CEO
Sold 10% of holdings ($27.6M position)135,407 shares left1x usual sizeFiling
- 4 Form 4 sale Loxo Oncology, Inc.Plan not statedAug 14, 2018 +35 days
Sold 20,000 shares at $159.41 ($3.2M)
Bilenker Joshua H., President & CEO
Sold 12.9% of holdings ($24.8M position)135,407 shares left1.3x usual sizeFiling
- 5 Form 4 sale Loxo Oncology, Inc.Plan not statedSep 13, 2018 +30 days
Sold 20,000 shares at $166.20 ($3.3M)
Bilenker Joshua H., President & CEO
Sold 12.9% of holdings ($25.8M position)135,407 shares left1.3x usual sizeFiling
- 6 Form 4 sale Loxo Oncology, Inc.Plan not statedOct 4, 2018 +21 days
Sold 20,000 shares at $164.94 ($3.3M)
Bilenker Joshua H., President & CEO
Sold 12.9% of holdings ($25.6M position)135,407 shares leftFirst sale on recordFiling
- 7 Form 4 sale Loxo Oncology, Inc.Plan not statedNov 27, 2018 +54 days
Sold 20,000 shares at $147.26 ($2.9M)
Bilenker Joshua H., President & CEO
Sold 10.8% of holdings ($27.2M position)164,407 shares left1.3x usual sizeFiling
- 8 Form 4 sale Loxo Oncology, Inc.Plan not statedDec 11, 2018 +14 days
Sold 20,000 shares at $135.47 ($2.7M)
Bilenker Joshua H., President & CEO
Sold 10.8% of holdings ($25M position)164,407 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2018 | Dec 12, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 20,000 | $2.7M | 10.8% | Plan not stated | SEC |
| Nov 27, 2018 | Nov 28, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 20,000 | $2.9M | 10.8% | Plan not stated | SEC |
| Oct 4, 2018 | Oct 5, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 20,000 | $3.3M | 12.9% | Plan not stated | SEC |
| Sep 13, 2018 | Sep 14, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 20,000 | $3.3M | 12.9% | Plan not stated | SEC |
| Aug 14, 2018 | Aug 15, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 20,000 | $3.2M | 12.9% | Plan not stated | SEC |
| Jul 10, 2018 | Jul 11, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $2.8M | 10.0% | Plan not stated | SEC |
| Jun 20, 2018 | Jun 21, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 57,000 | $10.2M | 26.8% | Unusual | SEC |
| May 15, 2018 | May 16, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $2M | 7.6% | Plan not stated | SEC |
| Apr 25, 2018 | Apr 26, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $2M | 7.6% | Plan not stated | SEC |
| Mar 14, 2018 | Mar 15, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $2M | 7.6% | Plan not stated | SEC |
| Feb 13, 2018 | Feb 14, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $1.4M | 7.6% | Plan not stated | SEC |
| Jan 17, 2018 | Jan 18, 2018 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $1.3M | 7.6% | Plan not stated | SEC |
| Dec 15, 2017 | Dec 18, 2017 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $1.2M | 7.6% | Plan not stated | SEC |
| Nov 28, 2017 | Nov 29, 2017 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $1.1M | 7.6% | Plan not stated | SEC |
| Oct 31, 2017 | Nov 1, 2017 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $1.3M | 7.4% | Plan not stated | SEC |
| Sep 19, 2017 | Sep 20, 2017 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $1.3M | 7.4% | Plan not stated | SEC |
| Aug 15, 2017 | Aug 16, 2017 | Loxo Oncology, Inc. | President & CEO | Form 4 sale | 15,000 | $1.1M | 7.4% | Plan not stated | SEC |